Researchers first to unlock key molecular mystery of premature aging syndromes

November 27, 2017, Florida State University

New research from Florida State University is beginning to piece together the stubborn puzzle posed by a family of rare and debilitating premature aging disorders.

Most of these diseases, called progeroid syndromes, share physiological symptoms characterized by the appearance of accelerated aging, such as skin disorders, loss of hair, skeletal and dental abnormalities and cardiovascular complications. Each individual progeroid syndrome is caused by its own specific genetic mutation, and researchers have struggled to describe what these different diseases have in common. This persistent mystery has limited scientists' exploration of potential therapies or treatments.

In a pioneering study published today in the journal Proceedings of the National Academy of Sciences, FSU researchers outlined the first discovery of a molecular commonality between two progeroid syndromes, Hutchinson-Gilford progeria syndrome and Rothmund-Thomson syndrome, and introduce a method for disease recognition that could yield additional breakthroughs in the future.

"There are many different individual mutations that can cause progeroid diseases, but nobody has been able to find any specific common quality between them," said postdoctoral researcher Juan Carlos Rivera-Mulia, the lead author of the study. "This research is the first discovery of a molecular commonality between two progeroid diseases with two different genetic causes."

In popular culture, notions of premature aging syndromes are typically expressed in the stories of fanciful characters like Benjamin Button, who ages backward out of his frail condition and emerges as a strapping, healthy middle-aged man. For the people who suffer from these diseases in the real world, life looks radically different.

In Hutchinson-Gilford progeria, children as young as 1 to 2 start developing a host of dramatic symptoms, and they die at an average age of 14. In Rothmund-Thomson syndrome, symptoms develop during childhood, and although life expectancy is not affected as dramatically, patients are predisposed to develop cancer. Progeroid syndromes are rare—one in 4 million newborns worldwide are diagnosed with Hutchinson-Gilford and there are 400 documented cases of Rothmund-Thomson—but there are no existing treatments or workable therapies for these diseases.

To better understand the underlying molecular mechanics of these disorders, researchers employed an advanced approach to disease marker discovery developed and refined at Florida State.

This method, called "DNA replication timing profiling," involves monitoring the order in which segments of DNA are duplicated in preparation for cell division.

Before a cell divides, it has to duplicate the roughly 15,000 chromosomal segments that compose its genome. This replication process is rigidly ordered, and originating from different tissues in the body have different orders of DNA segment replication. DNA in skin cells, for example, will have a different replication timing profile from DNA in cardiovascular cells.

In many diseases, this highly regulated and programmatic replication timing becomes disrupted. FSU researchers have found that characterization of these disruptions can reveal the fundamental molecular misfirings that give rise to different genetic disorders.

"We'd been studying the mechanism of how this is regulated, and we'd been trying to understand why the process is regulated differently in different cell types," said the J. Herbert Taylor Distinguished Professor of Biology David Gilbert, the senior author of the paper. "In the course of those studies, we recognized that this methodology could be very useful for the study of diseases like leukemia, and we've already used the system to identify alterations that can classify different leukemia subtypes."

For this study, Rivera-Mulia and his colleagues collected cells from progeroid patients and converted them to , allowing for a reliable model of human development. Researchers found that all abnormalities were erased when the cells were modified to stem cells, but when they were converted back into skin cells, the progeroid-related abnormalities gradually began to reemerge.

One early abnormality, an alteration in the gene TP63, was found to appear in both Hutchinson-Gilford and Rothmund-Thomson syndromes.

Not only was this the first time anyone had identified a molecular commonality between two progeroid syndromes—a monumental breakthrough in the study of these conditions—but it was also a resounding endorsement of the replication timing method's utility as an epigenetic tool for detecting markers of disease.

"This was more than just a discovery in progeroid ," Gilbert said. "This was the first novel finding using replication timing as a biomarker. We've shown we can find really interesting things with this method in leukemia, but until now, we'd yet to hit on something truly new. It's a pretty significant discovery."

The next step, Rivera-Mulia said, is to continue using to explore the development of progeroid syndromes in cell types that are most affected by these diseases and to trace the misregulations or abnormalities that occur during those processes.

If researchers can continue to map the molecular connections between these various premature aging diseases, the hope of finding a cure is not out of the question.

"We first need to identify the commonalities between these diseases and how they relate to natural and premature aging," Rivera-Mulia said. "If we can find the mechanistic causes of the alterations in these genes, and we can develop a targeted therapy, there's a chance we can one day find a cure."

Explore further: Mutation provides new insight into the molecular mechanisms of aging

More information: Juan Carlos Rivera-Mulia el al., "DNA replication timing alterations identify common markers between distinct progeroid diseases," PNAS (2017).

Related Stories

Mutation provides new insight into the molecular mechanisms of aging

May 5, 2011
A new study identifies the mutation that underlies a rare, inherited accelerated-aging disease and provides key insight into normal human aging. The research, published by Cell Press online May 5 in the American Journal of ...

Regulating asprosin levels might help control appetite and weight

November 7, 2017
Less than two years ago, researchers led by Dr. Atul Chopra, a medical geneticist at Baylor College of Medicine, discovered a new hormone called asprosin, that regulates blood-glucose levels. New studies on the hormone have ...

Protein turnover could be clue to living longer

August 30, 2017
It may seem paradoxical, but studying what goes wrong in rare diseases can provide useful insights into normal health. Researchers probing the premature aging disorder Hutchinson-Gilford progeria have uncovered an errant ...

Researchers find gene that causes progeroid and lipodystrophy syndrome

July 16, 2015
Researchers at the Translational Genomics Research Institute (TGen) have identified a genetic mutation associated with the appearance of premature aging and severe loss of body fat in children.

Scientists create new genetic model of premature aging diseases

April 29, 2011
Working with a group of national and international researchers, scientists from the Florida campus of The Scripps Research Institute have developed a new genetic model of premature aging disorders that could shed light on ...

Recommended for you

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Exercise-induced hormone irisin triggers bone remodeling in mice

December 13, 2018
Exercise has been touted to build bone mass, but exactly how it actually accomplishes this is a matter of debate. Now, researchers show that an exercise-induced hormone activates cells that are critical for bone remodeling ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Law professor suggests a way to validate and integrate deep learning medical systems

December 13, 2018
University of Michigan professor W. Nicholson Price, who also has affiliations with Harvard Law School and the University of Copenhagen Faculty of Law, suggests in a Focus piece published in Science Translational Medicine, ...

Pain: Perception and motor impulses arise in brain independently of one another

December 13, 2018
Pain is a negative sensation that we want to get rid of as soon as possible. In order to protect our bodies, we react by withdrawing the hand from heat, for example. This action is usually understood as the consequence of ...

Researchers give new insight to muscular dystrophy patients

December 13, 2018
New research by University of Minnesota scientists has revealed the three-dimensional structure of the DUX4 protein, which is responsible for the disease, facioscapulohumeral muscular dystrophy (FSHD). Unlike the majority ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.